Medicare Coverage Expands Access to GLP-1 Drugs, With 700,000 New Senior Users

1-Minute Brief

The expansion of Medicare coverage for GLP-1 medicines has significantly increased access and use among seniors, raising public health and policy c...

Key Facts

• Eli Lilly CEO stated that 700,000 new seniors have started GLP-1 medications since Medicare coverage began in July.
• Stopping GLP-1 drugs like Ozempic may increase the risk of heart attack and stroke, according to Axios.
• Eli Lilly reported that 70% of these new Medicare GLP-1 users are on Lilly drugs.
• Illinois Governor JB Pritzker revealed he has been on a GLP-1 regimen since 2024 and lost 80 pounds.
• The latest metrics on Medicare GLP-1 coverage expansion were released 15 hours ago, according to CNBC.

What Happened

Medicare's expanded coverage for GLP-1 drugs has led to a large increase in senior users, with Eli Lilly reporting significant uptake of its medications. Public figures, including Illinois Governor JB Pritzker, have also discussed personal use of GLP-1s.

Why It Matters

The rapid increase in GLP-1 use among seniors highlights evolving approaches to weight management and chronic disease, while raising questions about long-term health impacts and healthcare costs.

What's Next

Observers are monitoring the effects of broader GLP-1 access on public health outcomes and Medicare spending, as well as ongoing research into the risks of discontinuing these medications.